| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7186 |
| Human Intestinal Absorption | HIA- | 0.8597 |
| Caco-2 Permeability | Caco2- | 0.8875 |
| P-glycoprotein Substrate | Non-substrate | 0.5719 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8535 |
| Non-inhibitor | 0.9360 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8185 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8039 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8772 |
| CYP450 2D6 Substrate | Non-substrate | 0.8510 |
| CYP450 3A4 Substrate | Non-substrate | 0.6455 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9375 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9282 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9351 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8641 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9694 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9306 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9511 |
| Non-inhibitor | 0.8293 |
| AMES Toxicity | Non AMES toxic | 0.8944 |
| Carcinogens | Non-carcinogens | 0.9558 |
| Fish Toxicity | Low FHMT | 0.6524 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5000 |
| Honey Bee Toxicity | High HBT | 0.7278 |
| Biodegradation | Not ready biodegradable | 0.8386 |
| Acute Oral Toxicity | IV | 0.5550 |
| Carcinogenicity (Three-class) | Non-required | 0.6409 |